What is ADMA Biologics's shares (basic)?

ADMA Biologics (ADMA) reported shares (basic) of 236.1M in Q1 2026.

How has ADMA Biologics's shares (basic) changed year-over-year?

ADMA Biologics's shares (basic) decreased by 0.7% year-over-year, from 237.8M to 236.1M.

What is the long-term trend for ADMA Biologics's shares (basic)?

Over 4 years (2021 to 2025), ADMA Biologics's shares (basic) has grown at a 16.6% compound annual growth rate (CAGR), from 516.4M to 956.2M.

What does shares (basic) mean?

The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.

ADMA Biologics ADMA Shares (Basic)

Shares (Basic) at other companies

AbCellera Biologics Inc.ABCL

303.1M+1.8%

AnaptysBio, Inc.ANAB

28.7M-6.4%

ZymeworksZYME

74.7M-0.7%

Bio-Rad LaboratoriesBIO

27M-3.5%

Apogee Therapeutics, Inc.APGE

69.7M+19.7%

Quest DiagnosticsDGX

——

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.02B-54.5%

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's shares (basic)?: ADMA Biologics (ADMA) reported shares (basic) of 236.1M in Q1 2026.
How has ADMA Biologics's shares (basic) changed year-over-year?: ADMA Biologics's shares (basic) decreased by 0.7% year-over-year, from 237.8M to 236.1M.
What is the long-term trend for ADMA Biologics's shares (basic)?: Over 4 years (2021 to 2025), ADMA Biologics's shares (basic) has grown at a 16.6% compound annual growth rate (CAGR), from 516.4M to 956.2M.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.